Last reviewed · How we verify

NCT05157893

Effects of Virtual Reality (VR) Based Distraction and Relaxation Therapy on Moderate and Severe Pain

Status unknown NA Last updated 13 November 2024
What this trial tests

NA trial testing Virtual reality based analgesic therapy in Pain in 100 participants. Status unknown.

Timeline
1 December 2021
Primary endpoint
21 June 2025
21 December 2025

Quick facts

Lead sponsorXinhua Hospital, Shanghai Jiao Tong University School of Medicine
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment100
Start date1 December 2021
Primary completion21 June 2025
Estimated completion21 December 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Who can join

18 and older, any sex, with Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, single-arm, open, single-center clinical study. This study is a pilot study to explore the use of VR based distraction and relaxation therapy as an adjunctive analgesic method for Chinese patients with moderate to severe pain. After screening, patients with moderate to severe pain who meet the study inclusion criteria receive VR therapy for 15 minutes to evaluate the effectiveness and safety of VR therapy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The benefits and safety of a virtual reality intervention in patients suffering from acute and chronic pain: A pilot study.
    Ma B, Zhang L, Ji Y, Huang X, et al · · 2025 · cited 2× · PMID 39777063 · DOI 10.1177/20552076241308703

Verify or expand the search:

Other recruiting trials for Pain

Currently open trials in the same condition.

Other Xinhua Hospital, Shanghai Jiao Tong University School of Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05157893.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing